NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 286 filers reported holding NEKTAR THERAPEUTICS in Q4 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $7,000 | -22.2% | 429 | +14.7% | 0.00% | 0.0% |
| Q2 2020 | $9,000 | -40.0% | 374 | -55.7% | 0.00% | -66.7% |
| Q1 2020 | $15,000 | 0.0% | 845 | +21.1% | 0.00% | -25.0% |
| Q4 2019 | $15,000 | -87.0% | 698 | -89.0% | 0.00% | -88.9% |
| Q3 2019 | $115,000 | +55.4% | 6,349 | +206.6% | 0.04% | +38.5% |
| Q2 2019 | $74,000 | +64.4% | 2,071 | +54.3% | 0.03% | +13.0% |
| Q1 2019 | $45,000 | +28.6% | 1,342 | +25.1% | 0.02% | +9.5% |
| Q4 2018 | $35,000 | +105.9% | 1,073 | +279.2% | 0.02% | +110.0% |
| Q3 2018 | $17,000 | -5.6% | 283 | -22.7% | 0.01% | 0.0% |
| Q2 2018 | $18,000 | – | 366 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 1,350,000 | $22,950,000 | 1.87% |
| MAVERICK CAPITAL LTD | 6,655,625 | $113,146,000 | 1.81% |
| Camber Capital Management LP | 2,500,000 | $42,500,000 | 1.49% |
| Bellevue Group AG | 3,866,258 | $65,726,000 | 0.75% |
| Adero Partners, LLC | 51,500 | $876,000 | 0.75% |
| Goodman Financial Corp | 108,342 | $1,842,000 | 0.64% |
| CM Management, LLC | 35,000 | $595,000 | 0.55% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 424,504 | $7,217,000 | 0.43% |
| RICE HALL JAMES & ASSOCIATES, LLC | 568,379 | $9,662,000 | 0.34% |
| Burleson & Company, LLC | 107,736 | $1,832,000 | 0.32% |